tradingkey.logo
tradingkey.logo
検索

Neogenomics Inc

NEO
ウォッチリストに追加
14.970USD
+0.380+2.60%
終値 07/01, 16:00ET15分遅れの株価
1.95B時価総額
損失額直近12ヶ月PER

詳細情報 Neogenomics Inc 企業名

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Incの企業情報

企業コードNEO
会社名Neogenomics Inc
上場日Dec 10, 2012
最高経営責任者「CEO」Zook (Antony P)
従業員数2200
証券種類Ordinary Share
決算期末Dec 10
本社所在地9490 Neogenomics Way
都市FORT MYERS
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号33912
電話番号12397680600
ウェブサイトhttps://neogenomics.com/
企業コードNEO
上場日Dec 10, 2012
最高経営責任者「CEO」Zook (Antony P)

Neogenomics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--

よくある質問

Neogenomics Incの上位5名の株主は誰ですか?

Neogenomics Incの上位5名の株主は以下のとおりです。Mr. Jeffrey Scott (Jeff) Sherman

Neogenomics Inc(NEO)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Neogenomics Incの株式を保有している機関は564社あり、保有株式の総市場価値は約156.61Mで、全体の120.32%を占めています。2025Q4と比較して、機関の持ち株は7515333.00増加しています。

Neogenomics Incの最大の収益源は何ですか?

2026Q1において、Clinical Services-Client direct billing部門がNeogenomics Incにとって最大の収益を生み出しており、その金額は518.84Mで、全収益の71.34%を占めています。